Quarterlytics / Healthcare / Biotechnology / Revance Therapeutics

Revance Therapeutics

rvnc · NASDAQ Healthcare
Claim this profile
Ticker rvnc
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Employees 51-200
Overview Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management
← All annual reports
FY2023 Annual Report · Revance Therapeutics
Sign in to download
Loading PDF…